QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

ZBH

QT72Zimmer Biomet Holdings, Inc.
NYSE·Healthcare·Medical - Devices·USA
Latest market price
87.97
+0.81+0.93%
OverviewShort InterestFilings
ZBHQT72Zimmer Biomet Holdings, Inc.·NYSE
OverviewShort InterestFilings
87.97+0.93%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E22.33EPS (ttm)3.85
Insider Own0.30%
Shs Outstand193.46M
Perf Week0.95%
Market Cap16.86BForward P/E9.77EPS next Y9.01Insider Trans0.12%Shs Float-Perf Month2.20%
Enterprise Value23.91BPEG-EPS next Q1.99Inst Own-Short Float-Perf Quarter-2.08%
Income755.43MP/S2.01EPS this Y120.47%Inst Trans-Short Ratio-Perf Half Y-3.23%
Sales8.41BP/B1.34EPS next Y6.10%ROA3.35%Short Interest-Perf YTD-2.17%
Book/sh65.51P/C10.16EPS next 5Y6.97%ROE6.01%52W High108.28 -18.76%Perf Year-2.48%
Cash/sh2.19P/FCF9.19EPS past 3/5Y-ROIC5.26%52W Low79.12 11.19%Perf 3Y-
Dividend Est.0.96 (1.09%)EV/EBITDA10.84Sales past 3/5Y5.86% 6.08%Gross Margin70.03%Volatility1.52% 1.72%Perf 5Y-
Dividend TTM0.96 (1.09%)EV/Sales2.84EPS Y/Y TTM91.42%Oper. Margin15.61%ATR (14)2.26Perf 10Y-
Dividend Ex-DateJun 25, 2026Quick Ratio0.95Sales Y/Y TTM9.51%Profit Margin9.05%RSI (14)54.51Recom2.83
Dividend Gr. 3/5Y0.00% 0.59%Current Ratio1.73EPS Q/Q15.47%SMA202.16%Beta0.38Target Price96.33
Payout24.88%Debt/Eq0.59Sales Q/Q9.32%SMA501.06%Rel Volume1.91Prev Close87.16
Employees17,000LT Debt/Eq0.55EarningsAug 06SMA200-4.91%Avg Volume2.42MPrice87.97
IPO DateJul 25, 2001Option/ShortYes / YesEPS/Sales Surpr.12.37% 0.77%Net Debt/EBITDA3.19Volume4,614,309Change0.93%
Analyst Ratings
DateActionAnalystRatingTarget
Apr-29-26ReiteratedTruist Financial$98 → $92
Apr-29-26ReiteratedCanaccord GenuityHold$93 → $83
Apr-29-26ReiteratedStifel NicolausBuy$110 → $105
Apr-29-26ReiteratedRobert W. Baird$100 → $92
Apr-29-26ReiteratedBarclaysUnderweight$100 → $94
Mar-23-26DowngradeBTIGBuy → Neutral
Feb-12-26ReiteratedBarclaysUnderweight$105 → $100
Feb-11-26ReiteratedUBSSell$86 → $89
Jan-28-26ReiteratedUBSSell$96 → $86
Jan-09-26ReiteratedGoldman SachsNeutral$93
Latest News
Jun-15-26
Jun-15-2611:49AM
Is Zimmer Biomet Stock Underperforming the S&P 500?Yahoo
Jun-11-26
Jun-11-2608:13PM
Is Solventum Corporation (SOLV) A Good Stock To Buy Now?Yahoo
12:19AM
Why The Narrative Around Zimmer Biomet (ZBH) Is Shifting Without New Analyst UpdatesYahoo
12:19AM
Why The Narrative Around Zimmer Biomet (ZBH) Is Shifting Without New Analyst UpdatesYahoo
Jun-09-26
Jun-09-2602:30PM
Is Zimmer Biomet Holdings, Inc. (ZBH) A Good Stock To Buy Now?Yahoo
02:30PM
Is Zimmer Biomet Holdings, Inc. (ZBH) A Good Stock To Buy Now?Yahoo
02:07PM
Will ISRG's Cost Leverage Aid Margins Amid Tariff & Input Inflation?Yahoo
02:07PM
Will ISRG's Cost Leverage Aid Margins Amid Tariff & Input Inflation?Yahoo
02:01PM
Here's How GMED Is Capitalizing on the Musculoskeletal Market BoomYahoo
02:01PM
Here's How GMED Is Capitalizing on the Musculoskeletal Market BoomYahoo
Jun-08-26
Jun-08-2605:08PM
Zimmer Biomet Holdings, Inc. (ZBH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeekingAlpha
05:08PM
Zimmer Biomet Holdings, Inc. (ZBH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeekingAlpha
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue8,4098,2327,679
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A2,5193,1602,191
Gross Profit5,8895,0725,487
Selling, General and Administrative Excl. Other3,3433,2512,930
Research and Development451459437
Other Operating Expense7830835
Operating Income1,3121,3621,286
Interest Expense295293218
Unusual Expense
———
Non-Operating Income (Expense)10823931
Net Income Before Taxes9038311,037
Income Taxes142126131
Consolidated Net Income762705904
Net Income From Continuing Operations760705905
Net Income762705904
EPS (Recurring)3.873.564.45
EPS (Basic, Before Extraordinaries)3.873.564.45
EPS (Diluted)3.853.554.43
EBITDA2,2062,2172,251
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio22.8525.33—
Price To Sales Ratio2.042.16—
Gross Margin70.0361.6171.45
Operating Margin15.6016.5516.75
Net Margin9.068.5611.77
Shares Outstanding195198203
Market Capitalization17,15417,804—
Operating Lease Expense
———
Insider Trading Volume
$95.13$89.26$83.39$77.52$71.65● Close Price0.00K103.30K206.61K309.91K413.22KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Yi SangGroup President, Asia PacificMay 29 '26Sale82.645,000413,21627,251Jun 02 12:00 AM
Noor JehanzebSee remarks below.Apr 01 '26Option Exercise0.0013,252013,249Apr 03 12:00 AM
Winkler LoriSVP and CHROMar 12 '26Sale94.662,650250,84910,224Mar 16 12:00 AM
Tornos IvanChairman, President and CEOMar 06 '26Option Exercise0.0040,142092,118Mar 10 12:00 AM
Stellato Paul AVP, Controller, CAOMar 06 '26Option Exercise0.002,57705,890Mar 10 12:00 AM
Upadhyay SuketuExec VP, CFOMar 06 '26Option Exercise0.0019,335071,514Mar 10 12:00 AM
VAN ZUILEN WILFREDGroup Pres, EMEAMar 06 '26Option Exercise0.009,165031,553Mar 10 12:00 AM
Winkler LoriSVP and CHROMar 06 '26Option Exercise0.007,333013,503Mar 10 12:00 AM
Yi SangGroup President, Asia PacificMar 06 '26Option Exercise0.0011,778032,251Mar 10 12:00 AM
Phipps Chad FSee remarks below.Mar 06 '26Option Exercise0.008,880068,603Mar 10 12:00 AM
VAN ZUILEN WILFREDGroup Pres, EMEAFeb 25 '26Option Exercise0.006,364026,637Feb 27 12:00 AM
Phipps Chad FSee remarks below.Feb 25 '26Option Exercise0.005,252064,763Feb 27 12:00 AM
Yi SangGroup President, Asia PacificFeb 25 '26Option Exercise0.005,570022,837Feb 27 12:00 AM
Winkler LoriSVP and CHROFeb 25 '26Option Exercise0.004,694010,342Feb 27 12:00 AM
Upadhyay SuketuExec VP, CFOFeb 25 '26Option Exercise0.0012,728064,117Feb 27 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR